Partner Content Partner Content Registration opens for SMi’s 2nd Injectable Drug Delivery 20... Injectable Drug Delivery Conference 2019
Partner Content Partner Content Gene Therapy bringing new hope to patients and families Ophthalmic Drugs
Partner Content Partner Content Exclusive Interview Released from Santen for Ophthalmic Drug... Exclusive Interview Released from Santen
Partner Content Partner Content Explore New Strategies for Treating Retinal Vascular Disease... Ophthalmic Drugs 2018
Partner Content Partner Content Explore the future of ocular gene editing and strategic drug... Ophthalmic Drugs Conference
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
